The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Adjuvant radiation, androgen deprivation, and docetaxel for high-risk prostate cancer post-prostatectomy: Results of RTOG 0621.
Mark Hurwitz
Consultant or Advisory Role - Bayer/Algeta; Medivation
A. Oliver Sartor
Consultant or Advisory Role - Sanofi
Research Funding - Sanofi
Qiang Zhang
No relevant relationships to disclose
Ying Xiao
No relevant relationships to disclose
Bobby Shayegan
No relevant relationships to disclose
Paul W. Sperduto
No relevant relationships to disclose
Kas Ray Badiozamani
No relevant relationships to disclose
Colleen Anne Lawton
Honoraria - Elsevier
Eric M. Horwitz
No relevant relationships to disclose
Jeff M. Michalski
No relevant relationships to disclose
Kevin S. Roof
No relevant relationships to disclose
David Beyer
Consultant or Advisory Role - Bayer/Algeta; Ferring
Asha George
No relevant relationships to disclose
Howard Mark Sandler
Consultant or Advisory Role - Bayer/Algeta; Medivation; Sanofi